Fecal Immunochemical Test Positive: What Does It Mean?

A positive fecal immunochemical test (FIT) means the test detected hemoglobin, a protein in blood, in your stool sample. It does not mean you have colorectal cancer. In large screening programs, only about 3 to 6 percent of people who test positive and go on to have a colonoscopy turn out to have cancer. The rest have a range of findings, from precancerous polyps that can be removed on the spot to completely benign explanations like hemorrhoids. Still, a positive result is not something to ignore, because it is the screening tool’s way of flagging you for a closer look.

What a Positive FIT Actually Detects

FIT works by detecting human hemoglobin in a stool sample using antibodies specific to that protein. Because it targets human blood rather than blood from food, you do not need to restrict your diet or stop most medications before the test. That is a practical advantage over the older guaiac-based fecal occult blood test, which could react to red meat or certain vegetables and required dietary restrictions beforehand.

An important detail is that FIT is designed to pick up bleeding from the lower digestive tract. The antibodies react to intact hemoglobin, but hemoglobin from the upper gastrointestinal tract (the stomach or esophagus) gets broken down by digestive enzymes before it reaches the colon. In controlled studies, immunochemical tests did not detect upper GI blood at all.¹ So if you have a positive FIT, the blood is very likely coming from somewhere in the colon or rectum. That is exactly where colorectal cancers and precancerous polyps develop, which is what makes the test useful for screening.

The Odds of Cancer After a Positive FIT

This is the question most people want answered first, and the numbers are reassuring for the majority. In a large Dutch screening study using the OC-Light FIT, colonoscopy found cancer in about 3 percent of people who tested positive, while advanced adenomas (precancerous polyps large enough or abnormal enough to warrant removal) showed up in roughly 21 percent.² A screening study in Latin America found a somewhat higher cancer rate of about 6 percent and advanced adenomas in about 31 percent, likely reflecting differences in the population being screened and local risk factors.³

So for most people, a positive FIT leads to one of three outcomes at colonoscopy: nothing abnormal is found, one or more polyps are found and removed, or (less commonly) cancer is found. Finding and removing polyps before they turn cancerous is the main benefit of the entire screening process. Even a result that turns out to be a “false positive” for cancer often catches something worth treating.

Common Benign Causes of a Positive Result

A range of non-cancerous conditions can cause enough bleeding in the colon to trigger a positive FIT. Hemorrhoids are one of the most common culprits. Diverticular disease, inflammatory conditions, and even minor mucosal irritation can contribute. A large study examining factors behind false-positive FIT results found that hemorrhoids and diverticula were both significantly associated with increased odds of a positive result in the absence of cancer or advanced adenoma.⁴

That same study found other personal characteristics linked to false-positive results: older age, female sex, smoking, alcohol use, and higher body mass index all increased the likelihood of testing positive without having cancer. This does not mean these groups should skip follow-up. It simply means the test picks up bleeding that can come from many sources, and colonoscopy is how you sort out which source it is.

Do You Need to Stop Aspirin or Blood Thinners Before the Test?

This is a common concern, and the short answer is no. A nested case-control study found that the positive predictive value of FIT for significant neoplasia was not affected by ongoing anticoagulant therapy or chronic low-dose aspirin use.⁵ In practical terms, people taking these medications do not need to stop them before completing a FIT. While blood thinners might slightly increase the chance of any bleeding being detected, the clinical meaning of a positive result remains the same: colonoscopy is still indicated, and the chance of finding significant disease is comparable to someone not on these medications.

How Soon You Should Get a Colonoscopy

If your FIT comes back positive, your doctor will refer you for a colonoscopy. How quickly you get that colonoscopy matters, though not as urgently as some patients fear. A large study of over 70,000 patients found that there was no significant increase in the risk of being diagnosed with cancer or advanced-stage disease for colonoscopies performed within two, three, or even six months after a positive FIT, compared to those done within the first month.⁶ Risks started to climb in a meaningful way only after about nine months, and were significantly higher when the delay exceeded ten to twelve months.

The takeaway is practical: you do not need to panic if it takes a few weeks to schedule, but you should not let the referral sit for many months. A colonoscopy within a few months of a positive FIT keeps you well within the safety window. Delays beyond nine or ten months are where the evidence gets concerning.

The Problem of Not Following Up at All

A surprisingly large number of people who test positive on FIT never complete the follow-up colonoscopy. One study at a safety-net health system found that about 59 percent of patients with abnormal results did not complete a colonoscopy within a year.⁷ The reasons were a mix of patient-level barriers (fear of colonoscopy, competing health concerns), provider-level gaps (the doctor not being aware of the result), and system-level obstacles like scheduling difficulties and lack of transportation.

This is worth highlighting because a positive FIT without colonoscopy follow-up provides almost no benefit. The entire point of FIT-based screening is to identify people who need a closer look. If the closer look never happens, the screening was essentially wasted. If you have tested positive and feel anxious about colonoscopy, that anxiety is understandable and common. But the data consistently show that colonoscopy after a positive FIT catches treatable disease at an early stage, and that the procedure itself carries a low complication rate in experienced hands.

What Your Hemoglobin Level Tells Your Doctor

Some FIT tests are quantitative, meaning they report the actual concentration of hemoglobin in the sample rather than just a positive or negative result. This number carries additional information. Most programs use a cutoff of 20 micrograms of hemoglobin per gram of feces: anything at or above that level counts as positive. Some systems have experimented with lowering the cutoff to 10 micrograms per gram, which flags more people for colonoscopy but does not dramatically change the detection rate for cancer. At the lower threshold, about 12 percent of screened individuals test positive compared to about 7 percent at the standard cutoff.⁸

Higher hemoglobin concentrations in the stool are associated with a greater chance of serious findings at colonoscopy. Research has shown that male sex, older age, and higher fecal hemoglobin levels all independently predict the risk of advanced adenoma and colorectal cancer, and can be used to prioritize which patients should receive colonoscopy sooner.⁹ A decision-tree model found that people over 65 with hemoglobin levels above 100 micrograms per gram had about a 22 percent chance of cancer at colonoscopy, compared to far lower rates in younger patients with borderline-positive results.¹⁰ If your doctor mentions your hemoglobin concentration was especially high, that context explains why they may push for faster follow-up.

Could a Recent Colonoscopy Change the Meaning of a Positive FIT?

Some people test positive on FIT relatively soon after having had a colonoscopy. You might wonder whether the result means less if your colon was recently examined and cleared. It does change the probabilities, but it does not eliminate the risk. A study of over 177,000 patients with positive FIT results found that those who had undergone colonoscopy within the past five years had a cancer rate of about 0.7 percent, compared to roughly 3.9 percent among those who had not had a colonoscopy in over ten years or had never had one.¹¹ A recent clean colonoscopy substantially lowers your odds of cancer being the cause, but the positive FIT still warrants discussion with your doctor since polyps can develop in the interval, and a prior polypectomy actually increased the rate of cancer detection in subsequent positive FITs.

The Emotional Side of a Positive Result

Getting a letter or phone call saying your screening test is abnormal triggers real anxiety, even when you understand the statistics. Research on the psychological impact of false-positive FIT results found that cancer worry and psychological distress were elevated after receiving the positive result, but dropped significantly once the colonoscopy results came back showing no cancer.¹² However, even six months later, about 17 percent of people whose colonoscopy showed no abnormality still reported elevated cancer worry. A small proportion, about 5 percent, reported high levels of regret about participating in screening at all.

These findings suggest that the emotional burden of a false alarm is real and should not be dismissed. If you find yourself stuck in a worry loop after a positive-then-clear result, that is not unusual and it does not mean you are overreacting. Talking with your doctor about what the colonoscopy findings actually mean for your long-term risk can help put the experience in perspective.

What FIT Can Miss

No screening test is perfect, and FIT has a known blind spot. The test detects bleeding, so lesions that do not bleed much are harder to catch. Flat or sessile serrated polyps, which sit flush against the colon wall rather than protruding into the space, are much less likely to bleed than the more common raised polyps.¹³ These lesions are a recognized pathway to colorectal cancer, and some proportion of “interval cancers” (cancers that appear between screening rounds) likely arise from this type of growth. It is a limitation built into the test’s mechanism: if there is no blood in the stool, FIT cannot flag it.

This is why annual or biennial FIT screening works better than a one-time test. Repeating the test increases the cumulative chance of catching a lesion that bleeds intermittently. A systematic review of repeat FIT testing found that adding a second test increased positivity rates and reduced the number of missed cancers by over 50 percent in studies using a sensitive threshold.¹⁴ The trade-off is more colonoscopies, but for people at higher risk, that trade-off is worth it.

How Sample Handling Can Affect Your Result

One underappreciated factor is what happens to your stool sample between collection and the lab. Hemoglobin degrades over time, and heat speeds up that degradation. If your sample sits in a hot mailbox or in a warm car for too long, the measured hemoglobin level can drop enough to flip a true positive into a false negative. Studies of sample stability have shown that at room temperature, hemoglobin in the standard collection buffer remained reliable for about six days, while an improved buffer formulation extended that to about 20 days.¹⁵ At higher temperatures, the window shrinks dramatically.¹⁶

The practical lesson: collect your sample and return it to the lab or mail it as quickly as possible. Avoid leaving the kit in a hot environment. If you collect a sample on a Friday and the mail will not go out until Monday, store it in the refrigerator. Programs that mail FIT kits directly to patients have been shown to be effective and cost-effective at reaching people who might not otherwise get screened, but the success of that model depends partly on patients returning the kit promptly.¹⁷

FIT Compared to Multi-Target Stool DNA Tests

You may have seen advertisements for stool-based tests that combine hemoglobin detection with DNA markers (often sold under a brand name). These multi-target stool DNA tests cast a wider net: a recent meta-analysis found that next-generation versions detected about 46 percent of advanced precancerous lesions, compared to about 22 percent for FIT alone.¹⁸ That sounds like a clear win, but there is a trade-off: FIT had a specificity of about 96 percent, meaning very few healthy people got false alarms, while the DNA test’s specificity was about 92 percent. That difference means more people will be sent for colonoscopies that ultimately find nothing.

The tests also differ in logistics. FIT is cheap, simple, and recommended annually. Multi-target stool DNA tests cost substantially more and are typically recommended every three years. For population-level screening, the cost-effectiveness comparison depends on how you weigh sensitivity against false-positive rates and overall spending. Neither test is categorically better; they suit different situations and risk profiles.

What Happens After a Negative Colonoscopy Following a Positive FIT

If your colonoscopy after a positive FIT comes back clean, you are not simply back to square one. Research from a Taiwanese population-based screening program found that people who continued with periodic FIT after a negative colonoscopy had about half the rate of later colorectal cancer compared to those who stopped screening altogether.¹⁹ The benefit persisted whether the follow-up FIT came one, three, or five or more years later. People with higher hemoglobin concentrations on their original positive FIT also had a higher risk of later cancer, suggesting that even when colonoscopy finds nothing, a strongly positive FIT is a signal to stay on top of future screening.

Age, Sex, and the Push Toward Personalized Cutoffs

The standard FIT cutoff treats everyone the same, but researchers are exploring whether adjusting the threshold by age and sex could improve screening. A study of over half a million participants in the Netherlands found that using lower cutoffs for older participants and higher cutoffs for younger ones increased overall cancer detection by about 1 percent, increased adenoma detection by 5 percent, and reduced the number of colonoscopies needed by 7 percent.²⁰ Interval cancers, the ones that slip through between screening rounds, dropped by about 1.5 percent. The idea is that older adults and men are at higher baseline risk, so a lower bar for “positive” makes sense, while younger women with a slightly elevated result may be less likely to have serious disease and could be spared an unnecessary procedure.

This kind of risk-stratified approach is not yet standard practice in most screening programs, but it illustrates a broader shift in thinking. Rather than a single binary cutoff applied to every adult, future programs may incorporate age, sex, and the actual hemoglobin concentration to assign individualized colonoscopy urgency.²¹ For now, if your FIT comes back positive, the standard recommendation remains the same regardless of your demographic profile: get a colonoscopy.